403 related articles for article (PubMed ID: 10203100)
41. [Significance of soluble P-selectin in diagnosis of pre-disseminated intravascular coagulation state in children with severe pneumonia].
Wang CY; Song CM; Zheng QA
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):948-52. PubMed ID: 23324156
[TBL] [Abstract][Full Text] [Related]
42. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
43. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
44. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation.
Wada H; Sase T; Matsumoto T; Kushiya F; Sakakura M; Mori Y; Nishikawa M; Ohnishi K; Nakatani K; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2003 Jul; 9(3):233-40. PubMed ID: 14507112
[TBL] [Abstract][Full Text] [Related]
45. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
46. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
47. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
Kobayashi T; Terao T
Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
[TBL] [Abstract][Full Text] [Related]
48. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
[TBL] [Abstract][Full Text] [Related]
49. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
50. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
51. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
52. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
Gando S; Nanzaki S; Sasaki S; Kemmotsu O
Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
[TBL] [Abstract][Full Text] [Related]
53. [Diagnosis of predictive state of disseminated intravascular coagulation].
Yamamoto K; Saito H
Nihon Rinsho; 1993 Jan; 51(1):74-8. PubMed ID: 8433531
[TBL] [Abstract][Full Text] [Related]
54. [Correlations among FPB beta 15-42, PAC and D-dimer].
Gando S; Tedo I
Rinsho Byori; 1991 Sep; 39(9):972-6. PubMed ID: 1834876
[TBL] [Abstract][Full Text] [Related]
55. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.
Okugawa Y; Wada H; Noda T; Sakakura M; Nakasaki T; Watanabe R; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Nobori T; Shiku H
Am J Hematol; 2000 Nov; 65(3):210-4. PubMed ID: 11074537
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
57. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.
Yamada S; Asakura H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163216
[TBL] [Abstract][Full Text] [Related]
59. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Nishiyama T; Kohno Y; Koishi K
Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
[TBL] [Abstract][Full Text] [Related]
60. Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Asakura H; Sano Y; Omote M; Yoshida T; Ontachi Y; Mizutani T; Kaneda M; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
Int J Hematol; 2004 May; 79(4):394-9. PubMed ID: 15218973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]